Clinical Trial Update: Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of a radiolabeled monoclonal antibody for glioblastoma and anaplastic astrocytoma, sponsored by Peregrine Pharmaceuticals, has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma

Drugs mentioned

• Radiolabeled monoclonal antibody

Snippet

Sponsor: Peregrine Pharmaceuticals | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED